Dr. Li Jun holds a Ph.D. from Peking University and has completed postdoctoral research. As a Master’s Supervisor, his research focuses on the mechanisms of vasoactive drugs and their effects on cardiac/vascular homeostasis and remodeling. Throughout his career, he has successfully completed over 10,000 interventional procedures for various cardiovascular diseases.

Interventional treatment for complex and high-risk coronary heart disease; chemical ablation for hypertrophic obstructive cardiomyopathy; Renal Denervation (RDN) for refractory hypertension; myocardial biopsy; and comprehensive management of hyperlipidemia.

Dr. Li has led or participated in over 10 national and provincial-level Natural Science Foundation projects. He has published more than 40 academic papers and holds 8 national patents as the primary inventor.

· Vice Chairman, Youth Committee of the Cardiovascular Branch of Zhejiang Medical Association.

· Vice Chairman, Microcirculation Medication Professional Committee of the China Association of Traditional Chinese Medicine.

· Member, China Chronic Total Occlusion Cerebral Club (CTOCC).

· Member, Vascular Minimally Invasive Medicine Professional Committee of the China Medical Education Association.

· Member, Hypertension Professional Committee of the China Medical Education Association.

Member, Heart Valve Disease Group of the Cardiovascular Branch of Zhejiang Medical Association.